Loss of the Fus1-harboring 3p21.3 chromosomal region or decrease in the Fus1 mRNA and protein levels have been reported in the majority of lung cancers [13, 14], mesotheliomas [15], bone and soft tissue sarcomas [16], and many head–and–neck cancers [17]. This evidence concerns the gene TUSC2 and mesothelioma.